TRIM9 Antikörper
Kurzübersicht für TRIM9 Antikörper (ABIN7120301)
Target
Alle TRIM9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- TRIM9 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- tripartite motif-containing 9
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:5000, IP: 1:500-1:5000, IHC: 1:100-1:400
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- TRIM9 (Tripartite Motif Containing 9 (TRIM9))
-
Andere Bezeichnung
- TRIM9
-
Hintergrund
-
Synonyms: E3 ubiquitin-protein ligase TRIM9|RING finger protein 91|RING-type E3 ubiquitin transferase TRIM9|Tripartite motif-containing protein 9|TRIM9|KIAA0282|RNF91
Background: E3 ubiquitin-protein ligase which ubiquitinates itself in cooperation with an E2 enzyme UBE2D2/UBC4 and serves as a targeting signal for proteasomal degradation. May play a role in regulation of neuronal functions and may also participate in the formation or breakdown of abnormal inclusions in neurodegenerative disorders. May act as a regulator of synaptic vesicle exocytosis by controlling the availability of SNAP25 for the SNARE complex formation.
-
Molekulargewicht
- 60 kDa, 80 kDa
-
Gen-ID
- 114088
-
UniProt
- Q9C026
-
Pathways
- Synaptic Vesicle Exocytosis
Target
-